Bernstein Harold
President, R&D & CMO at MAZE
- Sold, on record
- $9.5M
- Dollars the filings state
- Form 4 sales
- 15
- Latest Oct 1, 2026
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MAZEMaze Therapeutics, Inc.President, R&D & CMO
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 4 sale MAZERoutineAug 13, 2026 2026
Sold 16,142 shares at $27.61 ($446k)
Bernstein Harold, President, R&D & CMO
10b5-1 planSold 100% of holdings ($446k position)0 shares left1.1x usual sizeFollows a Form 144Filing
- 2 Form 4 sale MAZERoutineSep 1, 2026 +19 days
Sold 16,141 shares at $26.36 ($425k)
Bernstein Harold, President, R&D & CMO
10b5-1 planSold 100% of holdings ($425k position)0 shares left1.1x usual sizeFollows a Form 144Filing
- 3 Form 144 notice MAZENoticeSep 2, 2026 +1 day
Filed to sell 10,685 shares ($284k)
Bernstein Harold, Officer
No 10b5-1 plan0.7x usual sizeFiling
- 4 Form 4 sale MAZEUnusualSep 3, 2026 +1 day
Sold 10,295 shares at $26.24 ($270k)
Bernstein Harold, President, R&D & CMO
No 10b5-1 planSold 51.5% of holdings ($525k position)9,705 shares left0.7x usual sizeFollows a Form 144Filing
- 5 Form 144 notice MAZENoticeSep 4, 2026 +1 day
Filed to sell 9,705 shares ($251k)
Bernstein Harold, Officer
10b5-1 plan0.6x usual sizeFiling
- 6 Form 4 sale MAZERoutineSep 4, 2026 same day
Sold 9,705 shares at $26.22 ($254k)
Bernstein Harold, President, R&D & CMO
10b5-1 planSold 100% of holdings ($254k position)0 shares left0.6x usual sizeFollows a Form 144Filing
- 7 Form 144 notice MAZENoticeOct 1, 2026 +27 days
Filed to sell 16,141 shares ($439k)
Bernstein Harold, Officer
10b5-1 plan1.1x usual sizeFiling
- 8 Form 4 sale MAZERoutineOct 1, 2026 same day
Sold 16,141 shares at $26.93 ($435k)
Bernstein Harold, President, R&D & CMO
10b5-1 planSold 100% of holdings ($435k position)0 shares left1.1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Oct 2, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 16,141 | $435k | 100.0% | Routine | SEC |
| Oct 1, 2026 | Oct 1, 2026 | MAZE | Officer | Form 144 notice | 16,141 | $439k | Notice | SEC | |
| Sep 4, 2026 | Sep 8, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 9,705 | $254k | 100.0% | Routine | SEC |
| Sep 4, 2026 | Sep 4, 2026 | MAZE | Officer | Form 144 notice | 9,705 | $251k | Notice | SEC | |
| Sep 3, 2026 | Sep 4, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 10,295 | $270k | 51.5% | Unusual | SEC |
| Sep 2, 2026 | Sep 2, 2026 | MAZE | Officer | Form 144 notice | 10,685 | $284k | Notice | SEC | |
| Sep 1, 2026 | Sep 3, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 16,141 | $425k | 100.0% | Routine | SEC |
| Aug 13, 2026 | Aug 14, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 16,142 | $446k | 100.0% | Routine | SEC |
| Jul 1, 2026 | Jul 2, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 14,609 | $437k | 100.0% | Routine | SEC |
| Jul 1, 2026 | Jul 1, 2026 | MAZE | Officer | Form 144 notice | 46,892 | $1.4M | Notice | SEC | |
| Jun 1, 2026 | Jun 3, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 14,853 | $381k | 100.0% | Routine | SEC |
| May 14, 2026 | May 18, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 15,000 | $393k | 100.0% | Routine | SEC |
| Apr 1, 2026 | Apr 2, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 15,000 | $442k | 100.0% | Routine | SEC |
| Mar 20, 2026 | Mar 20, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 15,000 | $736k | 100.0% | Routine | SEC |
| Mar 10, 2026 | Mar 12, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 30,000 | $1.5M | 100.0% | Routine | SEC |
| Mar 10, 2026 | Mar 10, 2026 | MAZE | Officer | Form 144 notice | 74,853 | $3.4M | Notice | SEC | |
| Feb 2, 2026 | Feb 4, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 15,000 | $690k | 100.0% | Routine | SEC |
| Jan 7, 2026 | Jan 9, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 25,156 | $1M | 100.0% | Routine | SEC |
| Jan 5, 2026 | Jan 6, 2026 | MAZE | President, R&D & CMO | Form 4 sale | 4,844 | $196k | 100.0% | Routine | SEC |
| Dec 29, 2025 | Dec 31, 2025 | MAZE | President, R&D & CMO | Form 4 sale | 45,000 | $1.8M | 100.0% | Routine | SEC |
| Dec 29, 2025 | Dec 29, 2025 | MAZE | Officer | Form 144 notice | 105,000 | $4.4M | Notice | SEC |